课题基金 / 基金详情

Development of a Nonhuman Primate Model of Polyomavirus Disease

Development of a Nonhuman Primate Model of Polyomavirus Disease
多瘤病毒病非人灵长类动物模型的开发
批准号:
8999709
负责人:
John Anthony Vanchiere
金额:
$70.62万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2018-12-31

项目摘要

项目成果

John Anthony Vanchiere的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The human polyomaviruses are increasingly important opportunistic pathogens among the growing population of immune compromised patients, including those with solid organ transplants and patients receiving immune suppressive treatments for cancer, autoimmune and neurologic diseases. The lack of an animal model of polyomavirus disease has limited our ability to study the mechanisms of immunologic control of polyomaviruses and to develop preventative and therapeutic strategies that could reduce the long-term sequelae of polyomavirus diseases. This 36-month project will build on the established partnership of the Principal Investigator and the NIH-funded Squirrel Monkey Breeding and Research Resource (SMBRR) to: 1) characterize the reactivation of the squirrel monkey polyomavirus (SMPyV) under conditions of immune suppression that predispose to human polyomavirus disease; 2) explore the ability of human polyomaviruses to infect and cause disease in squirrel monkeys; and, 3) test the ability of available antiviral agents to ameliorate polyomavirus reactivation. The proposed studies will broaden the scope of research at the SMBRR to include molecular virologic and immunologic techniques relevant to the health of squirrel monkeys used for biomedical research. In addition, these studies will deliver a model system that can be utilized by other researchers to study the pathogenesis of polyomavirus diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LSUHSC COBRE: IMMUNE CORRELATES OF BKV PERSISTENCE AND REACTIVATION
LSUHSC COBRE: IMMUNE CORRELATES OF BKV PERSISTENCE AND REACTIVATION
LSUHSC COBRE: IMMUNE CORRELATES OF BKV PERSISTENCE AND REACTIVATION
海外基金